Article Text

Download PDFPDF
Hodgkin's disease and the Epstein-Barr virus
  1. K J Flavell2,
  2. P G Murray1
  1. 1The School of Health Sciences, University of Wolverhampton, Wolverhampton WV1 1DJ, UK
  2. 2The Department of Pathology, Division of Cancer Studies, Medical School, University of Birmingham, Birmingham B15 2TT, UK
  1. Dr Murray p.g.murray{at}


Hodgkin's disease is an unusual cancer because the malignant cells constitute only a minority of the total tumour mass and, as a consequence, the study of these cells has been a major challenge. Recently, the application of newer technologies, such as single cell polymerase chain reaction (PCR) and gene expression array analysis, to the study of Hodgkin's disease have yielded new insights into the pathogenesis of this tumour. In addition, the recognition that a proportion of Hodgkin's disease tumours harbour the Epstein-Barr virus (EBV) and that its genome is monoclonal in these tumours suggests that the virus contributes to the development of Hodgkin's disease in some cases. This review summarises current knowledge of the pathogenesis of Hodgkin's disease with particular emphasis on the association with EBV. J Clin Pathol: Mol Pathol

  • Hodgkin's disease
  • Epstein-Barr virus
  • Hodgkin-Reed Sternberg cells

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.